Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23717018 | 0.82 | LMNA (0.30) | LMNA | |
| SCHEMBL8896607 | 0.76 | ALDH1A1 (0.37) | LMNATSHRALDH1A1 | |
| SCHEMBL19473677 | 0.74 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL497097 | 0.71 | TSHR (0.39) | TSHRALDH1A1FFAR3LCKFYN | |
| SCHEMBL12057307 | 0.71 | LMNA (0.33) | LMNATSHRALDH1A1THPOFFAR3 | |
| SCHEMBL2331497 | 0.71 | ALDH1A1 (0.32) | TSHRALDH1A1 | |
| SCHEMBL9400179 | 0.69 | CHRM2 (0.33) | TSHRALDH1A1 | |
| SCHEMBL8101247 | 0.69 | MEN1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL3063397 | 0.69 | ALDH1A1 (0.30) | TSHRALDH1A1 | |
| SCHEMBL42772 | 0.69 | LMNA (0.35) | LMNATSHRALDH1A1THPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5476743-A | Thermoplastic resin, a charge director, a liquid component, an additive selected from cyclic carbonates, cyclic sulfones, cyclic sulfoxides and organic amides, pigments, and a charge adjuvant | XEROX CORPORATION (US) | 1995-12-19 | — | — | US | claimed |
| EP-4622953-A1 | PREPARATION OF 4-CYANOBENZOYL CHLORIDES FROM ALKALI METAL 4-CARBAMOYL-BENZOATES | BASF SE (DE) | 2025-10-01 | — | — | EP | disclosed |
| US-20240226309-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB | Synthorx, Inc. (US) | 2024-07-11 | — | — | US | disclosed |
| US-20230357467-A1 | FLUORINE-CONTAINING COPOLYMER PRODUCTION METHOD AND FLUORINE-CONTAINING COPOLYMER | AGC Inc. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-11597873-B2 | Well treatment compositions and methods comprising certain microemulsions and certain clay control additives exhibiting synergistic effect of enhancing clay swelling protection and persistency | FLOTEK CHEMISTRY, LLC (US) | 2023-03-07 | — | — | US | disclosed |
| US-11407930-B2 | Compositions and methods for enhancement of production of liquid and gaseous hydrocarbons | FLOTEK CHEMISTRY, LLC (US) | 2022-08-09 | — | — | US | disclosed |
| CN-111548541-B | Air cushion layer for ink transfer medium and preparation method and application thereof | 江苏康普印刷科技有限公司 | 2022-04-22 | — | — | CN | disclosed |
| US-20220073812-A1 | DILUTED MICROEMULSIONS WITH LOW SURFACE TENSIONS | FLOTEK CHEMISTRY, LLC (US) | 2022-03-10 | — | — | US | disclosed |
| US-11254856-B2 | Methods and compositions for use in oil and/or gas wells | FLOTEK CHEMISTRY, LLC (US) | 2022-02-22 | — | — | US | disclosed |
| US-20210371730-A1 | WELL TREATMENT COMPOSITIONS AND METHODS COMPRISING CERTAIN MICROEMULSIONS AND CERTAIN CLAY CONTROL ADDITIVES EXHIBITING SYNERGISTIC EFFECT OF ENHANCING CLAY SWELLING PROTECTION AND PERSISTENCY | FLOTEK CHEMISTRY, LLC (US) | 2021-12-02 | — | — | US | disclosed |
| EP-0626174-A2 | Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-30 | — | — | EP | disclosed |
| US-5352659-A | Polypeptide; hypotensive agents | TAKEDA CHEMICAL INDUSTRIES (JP) | 1994-10-04 | — | — | US | disclosed |
| US-5306808-A | Endothelin derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1994-04-26 | — | — | US | disclosed |
| US-5224987-A | Aqueous carriers with colors and tertiary amide penetrants | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0547317-A1 | Endothelin antagonists | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-06-23 | — | — | EP | disclosed |
| EP-0546409-A1 | Method for the preparation of tetrahydropyrancarboxylic esters | BASF Aktiengesellschaft (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0499266-A1 | Endothelin antagonist | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-19 | — | — | EP | disclosed |
| EP-0470256-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 1992-02-12 | — | — | EP | disclosed |
| WO-1991013089-A1 | PEPTIDE DERIVATIVES AND PRODUCTION THEREOF | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-09-05 | — | — | WO | disclosed |
| US-3939109-A | Polyamic-acids prepared from 3,3,4,4-benzhydrol tetracarboxylic dianhydride | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226309-A1 | HEAD AND NECK CANCER COMBINATION THERAPY COMPRISING AN IL-2 CONJUGATE AND CETUXIMAB | IL2, IL2RA, CD22 | LMNA 4662/4885TSHR 395/4885ALDH1A1 891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.